Chas Bountra trained at King’s College London and the University of Edinburgh before taking up a post-doctoral fellowship and college lectureship in Physiology at Oxford. He then worked for 19 years in the pharmaceutical industry, where he was involved in the development of candidate drugs for several diseases, including novel treatments for cancer chemotherapy and Irritable Bowel Syndrome. He returned to Oxford as Professor of Translational Medicine in the Nuffield Department of Clinical Medicine and as an Associate Member of the Department of Pharmacology. Professor Bountra is currently working with 9 pharmaceutical companies, 8 disease foundations and more than 100 academic labs to develop new drugs for a range of common and rare diseases. He leads the University’s innovation activities at regional, national and international level.